CN1861058A - Micro-capsule soybean isoflavone and its prepn. method - Google Patents
Micro-capsule soybean isoflavone and its prepn. method Download PDFInfo
- Publication number
- CN1861058A CN1861058A CN 200610086965 CN200610086965A CN1861058A CN 1861058 A CN1861058 A CN 1861058A CN 200610086965 CN200610086965 CN 200610086965 CN 200610086965 A CN200610086965 A CN 200610086965A CN 1861058 A CN1861058 A CN 1861058A
- Authority
- CN
- China
- Prior art keywords
- soybean isoflavone
- cyclodextrin
- capsule
- solution
- micro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A soybean isoflavone Microsoft capsule is prepared from the soybean isoflavone as core material and beta-cyclodextrin as wall material through dissolving, proportional mixing, stirring, colloid grinding and drying.
Description
Technical field
The invention belongs to health product and technical field of food additives, particularly relate to a kind of micro-capsule soybean isoflavone and preparation technology.
Background technology
The main active of soybean isoflavone is similar to mammiferous estrogen glycol with molecular structure, and diphenol hydroxyl activity group is arranged, and it can combine with the intravital estrogen receptor of biology and show certain estrogen function; Secondly, the polyphenol structure of soybean isoflavone has stronger antioxygen physical ability power and good removing free radical ability, can form stable free radical intermediate, thus the blocking-up radical reaction.In addition, soybean isoflavone also has anti-hemolysis function and antiserum lipoprotein lipid peroxidation, so hyperlipidemia, atherosclerosis, coronary heart disease etc. are all had certain prevention and auxiliary treatment effect.
Soybean isoflavone mainly has the health-care effect that prevents climacteric syndrome, and it can substitute the natural component of estrin treatment.And estrogen has been proved to be very unique and fast to the effect of alleviating climacteric syndrome, but estrin treatment has potential carcinogenesis in the past, can cause female breast cancer and in utero black cancer.Soybean isoflavone substitutes estrogen and also has the pass with feminine charm, and the women is the ovarian function decline after 35 years old, and the secretion of body inner estrogen reduces, and it is old and feeble that skin easily shows, and in time replenishes soybean isoflavone, can improve women's appearance, the elegance that retains youth, and has no side effect; Soybean isoflavone is hypercholesterolemia reducing effectively, and low density lipoprotein, LDL (LDL) is prevented and treated the cardiovascular disease effect.Because it is closely related that female osteoporosis and body inner estrogen lack, and soybean isoflavone also can prevent osteoporosis.
Soybean isoflavone is that raw material makes by bean cake or bean product leftover bits and pieces usually, be generally glucoside, become aglycon through enzymolysis, but this soybean isoflavone has bigger foreign odor flavor, be difficult to directly take, therefore, how to eliminate the existing foreign odor flavor of soybean isoflavone, to become a problem that presses for solution.
Summary of the invention
The object of the present invention is to provide a kind of raw material foreign odor of can eliminating to distinguish the flavor of, improve the quality of products, strengthen its stable micro-capsule soybean isoflavone and preparation technology.
The objective of the invention is to adopt such technical solution to realize: as core, β-CD cyclodextrin is the wall material with soybean isoflavone, and the content of described each material composition is: soybean isoflavone 50-95%, β-CD cyclodextrin 5-50%.
Micro-capsule soybean isoflavone of the present invention, its preparation technology is: β-CD cyclodextrin it is characterized in that adopting dissolve, mixes, mistake colloid mill and drying process make, wherein the solution temperature condition is 20-80 ℃.
β-CD cyclodextrin that the present invention adopts, its ring-type stereochemical structure is hydrophobicity tubular cavity, hydroxyl on β-CD glycosyl all is arranged in the outside of ring, be hydrophilic, the hydrophobic group of the soybean isoflavone guest molecule that it can be complementary with the molecule specification forms stable supermolecule inclusion compounds, reaches the effect of eliminating raw material foreign odor flavor, strengthening its stability, improve the quality of products and enlarge the scope of application.
The specific embodiment
Embodiment 1:
Raw soybeans isoflavone and β-CD cyclodextrin all can be buied from market, and each raw material constituent is soybean isoflavone 60%, β-CD cyclodextrin 40%; Its preparation technology is: earlier β-CD cyclodextrin is dissolved into supersaturated solution, and 60 ℃ of solution temperatures, mixing in the soybean isoflavone adding supersaturated solution, crossing colloid mill, the reuse spray drying got final product in 24 hours;
Embodiment 2:
Raw material constituent required for the present invention is soybean isoflavone 50%, β-CD cyclodextrin 50%; Its preparation technology is: earlier β-CD cyclodextrin is dissolved into supersaturated solution, and 80 ℃ of solution temperatures, mixing in the soybean isoflavone adding supersaturated solution, crossing colloid mill, the reuse lyophilization got final product in 24 hours;
Embodiment 3:
Raw material constituent required for the present invention is soybean isoflavone 70%,, β-CD cyclodextrin 30%; Its preparation technology is: earlier β-CD cyclodextrin is dissolved into supersaturated solution, and 70 ℃ of solution temperatures, mixing in the soybean isoflavone adding supersaturated solution, crossing colloid mill, the reuse lyophilization got final product in 24 hours;
Product after tested, demonstrated without the soybean isoflavone of technology inclusion of the present invention by gas chromatogram and to compare with the product after the inclusion, peak of curve has very big-difference, from sense organ relatively, deodorizing effect is good, meets the requirement of using as functional component, food additive or health food.
Claims (5)
1, micro-capsule soybean isoflavone, as core, β-CD cyclodextrin is the wall material with soybean isoflavone, the content of described each composition is: soybean isoflavone 50-95%, β-CD cyclodextrin 5-50%.
2, according to the described micro-capsule soybean isoflavone of claim 1, its step of preparation process is: β-CD cyclodextrin dissolving, mixing are stirred, are crossed colloid mill and drying process, and wherein the solution temperature condition is 20-80 ℃.
3,, it is characterized in that described each raw material constituent is soybean isoflavone 60%, β-CD cyclodextrin 40% according to the described micro-capsule soybean isoflavone of claim 1; Its preparation technology is: earlier β-CD cyclodextrin is dissolved into supersaturated solution, and 60 ℃ of solution temperatures, mixing in the soybean isoflavone adding supersaturated solution, crossing colloid mill, the reuse spray drying got final product in 24 hours.
4,, it is characterized in that described each raw material constituent is soybean isoflavone 50%, β-CD cyclodextrin 50% according to the described micro-capsule soybean isoflavone of claim 1; Its preparation technology is: earlier β-CD cyclodextrin is dissolved into supersaturated solution, and 80 ℃ of solution temperatures, mixing in the soybean isoflavone adding supersaturated solution, crossing colloid mill, the reuse lyophilization got final product in 24 hours.
5,, it is characterized in that described each raw material constituent is soybean isoflavone 70%, β-CD cyclodextrin 30% according to the described micro-capsule soybean isoflavone of claim 1; Its preparation technology is: earlier β-CD cyclodextrin is dissolved into supersaturated solution, and 70 ℃ of solution temperatures, mixing in the soybean isoflavone adding supersaturated solution, crossing colloid mill, the reuse lyophilization got final product in 24 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610086965 CN1861058A (en) | 2006-06-21 | 2006-06-21 | Micro-capsule soybean isoflavone and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610086965 CN1861058A (en) | 2006-06-21 | 2006-06-21 | Micro-capsule soybean isoflavone and its prepn. method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1861058A true CN1861058A (en) | 2006-11-15 |
Family
ID=37388645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610086965 Pending CN1861058A (en) | 2006-06-21 | 2006-06-21 | Micro-capsule soybean isoflavone and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1861058A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101780203A (en) * | 2010-03-16 | 2010-07-21 | 刘仁杰 | Lubrication effervescent agent for yin nourishing, nest warming, body deodorizing and youth keeping and preparation method thereof |
| CN102652736A (en) * | 2012-04-16 | 2012-09-05 | 河南科技大学第一附属医院 | Method for preparing soybean isoflavone sustained-release microspheres |
| CN104984362A (en) * | 2015-07-30 | 2015-10-21 | 淄博千汇生物科技有限公司 | Preparation method of isoflavone cyclodextrin clathrate |
-
2006
- 2006-06-21 CN CN 200610086965 patent/CN1861058A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101780203A (en) * | 2010-03-16 | 2010-07-21 | 刘仁杰 | Lubrication effervescent agent for yin nourishing, nest warming, body deodorizing and youth keeping and preparation method thereof |
| CN102652736A (en) * | 2012-04-16 | 2012-09-05 | 河南科技大学第一附属医院 | Method for preparing soybean isoflavone sustained-release microspheres |
| CN102652736B (en) * | 2012-04-16 | 2013-08-21 | 河南科技大学第一附属医院 | Method for preparing soybean isoflavone sustained-release microspheres |
| CN104984362A (en) * | 2015-07-30 | 2015-10-21 | 淄博千汇生物科技有限公司 | Preparation method of isoflavone cyclodextrin clathrate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rafiq et al. | Citrus peel as a source of functional ingredient: A review | |
| Lu et al. | Citrus flavonoids in fruit and traditional Chinese medicinal food ingredients in China | |
| Mendes et al. | Towards comprehensive utilization of winemaking residues: Characterization of grape skins from red grape pomaces of variety Touriga Nacional | |
| Wang et al. | Effects of molecular structure of polyphenols on their noncovalent interactions with oat β-glucan | |
| KR101121543B1 (en) | Composition comprising starch or dietary fiber from gramineae plant for prevention and treatment of ischemic diseases and degenerative brain diseases | |
| Hu et al. | Comparison in bioactivity and characteristics of Ginkgo biloba seed polysaccharides from four extract pathways | |
| Nguyen et al. | Isolation and characteristics of polysaccharide from Amorphophallus corrugatus in Vietnam | |
| Zhang et al. | Structural elucidation and bioactivities of a novel arabinogalactan from Coreopsis tinctoria | |
| JP2017529835A (en) | Ginseng extract containing ginseng or ginseng containing a rare ginsenoside, or a method for producing ginseng-forming plant stem cells or extracts thereof | |
| US10314915B2 (en) | Catechin bioavailability enhancer comprising cyclodextrin | |
| Kuo et al. | Preparation and physicochemical properties of whole-bean soymilk | |
| JPWO2006019114A1 (en) | Whitening agent containing polyphenol compound | |
| KR20130014451A (en) | Composite comprising steviol glycoside or licorice, and poorly soluble agent | |
| CN1861058A (en) | Micro-capsule soybean isoflavone and its prepn. method | |
| TWI227661B (en) | Water-soluble bean-based extracts | |
| Li et al. | Structure characterization and biological activities evaluation of two hetero-polysaccharides from Lepista nuda: Cell antioxidant, anticancer and immune-modulatory activities | |
| Pal et al. | Fenugreek (Trigonella foenum) seeds in health and nutrition | |
| Ho et al. | Green extraction of polyphenolic-polysaccharide conjugates from Pseuderanthemum palatiferum (Nees) Radlk.: Chemical profile and anticoagulant activity | |
| Pak et al. | Structural characterization and anti-oxidation activity of pectic polysaccharides from Swertia mileensis | |
| Zeng et al. | Potential of longan (Dimocarpus longan Lour.) in functional food: A review of molecular mechanism-directing health benefit properties | |
| KR102393417B1 (en) | Antidiabetic composition comprising Hemp stem extract | |
| JP2008266156A (en) | Heparin-binding epidermal growth factor-like growth factor gene expression promoter containing plant extract | |
| JP2007186483A (en) | Food product for treatment of menopausal symptom | |
| KR20140040413A (en) | A method for the preparation of extract containing decursinol angelate from a leaf of angelica gigas radix and the composition containing the extract | |
| Ullah et al. | A comprehensive review on recent xanthine oxidase inhibitors of dietary based bioactive substances for the treatment of hyperuricemia and gout: molecular mechanisms and perspective |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20061115 |